The Oregon Translational Research and Drug Discovery Institute at Oregon State University was founded
In 2007, The Oregon Translational Research and Drug Discovery Institute (OTRADI) at Oregon State University was established by…
Biotechnology | Life Science News | Medical Device | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
Vanderbilt Center for Neuroscience Drug Discovery was founded
In 2007, the Vanderbilt Center for Neuroscience Drug Discovery was established, combining the expertise of four groups of…
The St Jude LIFE study on long-term effects of cancer and its treatment launched
In 2007, The St. Jude LIFE study on the long-term effects of cancer and its treatment began. This…
The Cancer Prevention and Research Institute of Texas was founded
In 2007, Texas voters overwhelmingly approved a constitutional amendment that established the Cancer Prevention and Research Institute of…
Texas Biomed geneticists announced discovery that a particular gene, VNN1, plays a major role in the regulation of HDL cholesterol levels
In 2007, Texas Biomed geneticists announced their discovery that a particular gene, VNN1, plays a major role in…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Therapeutics
The Center for Clinical and Translational Research was founded at Virginia Commonwealth University
In 2007, the Center for Clinical and Translational Research (CCTR) was founded at Virginia Commonwealth University to enhance…
R Paul Robertson received two NIDDK grants totaling to improve islet transplantation
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…
Cocrystal Discovery (Cocrystal Pharma) was founded
In 2007, Cocrystal Discovery, now known as Cocrystal Pharma, was founded in Bothell as a pharmaceutical company with…
Jubilant Organosys acquired Hollister-Stier
On Apr. 25, 2007, Jubilant Organosys, Ltd. announced it had acquired Spokane-based Hollister-Stier for $122.5 million. The plant…
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
The Animal Enterprise Terrorism Act was signed into lawﾠ
On Nov. 27, 2006, the Animal Enterprise Terrorism Act (AETA) was officially signed into law by President George…
Biotechnology | Diagnostics | Genomics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Washington University received its largest grant ever for the Genome Sequencing Center
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
The National Cancer Institute released preliminary data on genetic susceptibility for prostate cancer
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
ICOS Corp announced agreement to be acquired by Eli Lilly and Company
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | NIH | Oncology | Therapeutics
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
The Virginia Bioinformatics Institute opened new office complex in the National Capital Region
On Sept. 28, 2006, the Virginia Bioinformatics Institute (VBI) opened its new office complex in the National Capital…
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
Integrated DNA Technologies acquired Belgian manufacturer and established European operating base in Leuven, Belgium
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
The OMRF celebrated it’s 60th anniversary
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
BD acquired TriPath Imaging for $350 million
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
John E Niederhuber became the thirteenth director of the National Cancer Institute
On Aug. 16, 2006, President Bush announced that he intended to appoint John E. Niederhuber, M.D., to be…
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Pharmaceutical | Therapeutics
The Frances Langford Heart Center opened its doors
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…